UPDATE: AstraZeneca Asks Investors For Time As It Predicts Strong Growth From 2017
LONDON (Alliance News) - British drugs company AstraZeneca PLC Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly once it has invested in its pipeline and transformed the company over th Read More